Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo. - Wikidata - wikimedia - TriplyDB

Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

http://www.wikidata.org/entity/Q34099771

about

Expression and characterization of a codon-optimized blood coagulation factor VIII.

P2860

Q30397756-15861E32-5A02-4051-8DB4-ED3C75C1D96E

P2860

Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

http://www.wikidata.org/entity/Q34099771

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effects of replacement of fact ...... survival and efficacy in vivo.

@ast

Effects of replacement of fact ...... survival and efficacy in vivo.

@en

Effects of replacement of fact ...... survival and efficacy in vivo.

@nl

type

label

Effects of replacement of fact ...... survival and efficacy in vivo.

@ast

Effects of replacement of fact ...... survival and efficacy in vivo.

@en

Effects of replacement of fact ...... survival and efficacy in vivo.

@nl

prefLabel

Effects of replacement of fact ...... survival and efficacy in vivo.

@ast

Effects of replacement of fact ...... survival and efficacy in vivo.

@en

Effects of replacement of fact ...... survival and efficacy in vivo.

@nl

P1433

Q34099771-23E960A7-DE54-477E-B943-A882502DD581

P1476

Q34099771-3C87DAD2-68D4-4890-B908-4E6BF1F978B0

P2093

Q34099771-0AA5FB8D-65DC-4E88-9F5D-04C8E172C4F9

Q34099771-2F3AA276-63C0-47D5-AE6F-2FEF45DE8B93

Q34099771-4C170447-DC10-4798-99D7-56816BFE9D2A

Q34099771-64205BE1-D78B-43C4-B40E-2DEF7F7245CE

P2860

Q34099771-158A8B3C-43B8-43D9-A192-60D987BA2981

Q34099771-21602F4C-E2D9-4C6B-A917-D4C49BCFBD9C

Q34099771-26E0E207-3A85-4704-A00A-2BE4C21FC0B8

Q34099771-34A83A1C-DF2D-4B17-912A-5BDD17BC58CA

Q34099771-34FDC771-29C4-414D-B95F-1ACFFD677E59

Q34099771-38FE251F-62EF-4BD7-946C-B71ED0639C3B

Q34099771-44BA8603-E808-4476-B474-B1DFF779AA1A

Q34099771-46E6DEAE-E72A-48C9-BEAB-C63BD6764613

Q34099771-4F5E4320-F4C5-4F23-A3D0-C5F7C938B4A7

Q34099771-5654358C-2D42-4C10-B245-413F43873B3D

P2888

Q34099771-DC7D7525-8EF1-4A76-8B80-6100A4A833D5

P304

Q34099771-56936337-03A4-4DF7-A645-D966BC782E48

P31

Q34099771-31EEBD30-AB2D-4847-AC2E-E498814AFDD6

P356

Q34099771-07014023-E99C-4CD0-BD41-17DE650E3F39

P407

Q34099771-AE5C4BCF-5685-4486-97AC-998AED68B5A8

P433

Q34099771-8D0FB0CE-F650-41B8-93F1-E829F007D2A0

P478

Q34099771-7C6F582B-DD33-48D3-832D-6E226B46FB5B

P50

Q34099771-BEA8FD51-DF36-45ED-9CF6-F921E35B6B89

P577

Q34099771-E99F1848-D57E-47B2-B763-FA9EB9891B34

P5875

Q34099771-D497C61A-0EEB-4A89-8BFF-1C6898CC9724

P6179

Q34099771-82B1EB1C-35B9-406D-A253-A49ACC871CB4

P698

Q34099771-161B3375-1867-4830-83E2-3363B45A7362

P932

Q34099771-8EF807A8-9731-4C1C-9D1C-7FBBEDF7DB43

P356

S12248-014-9627-2

P1433

The AAPS Journal

P1476

Effects of replacement of fact ...... survival and efficacy in vivo

@en

P2093

Hironao Wakabayashi

http://www.w3.org/2001/XMLSchema#string

Krithika A Shetty

http://www.w3.org/2001/XMLSchema#string

Philip J Fay

http://www.w3.org/2001/XMLSchema#string

Sathy V Balu-Iyer

http://www.w3.org/2001/XMLSchema#string

P2860

The tertiary structure and domain organization of coagulation factor VIII

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice

Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A mice.

Activation of factor VIII and mechanisms of cofactor action.

Clustered basic residues within segment 484-510 of the factor VIIIa A2 subunit contribute to the catalytic efficiency for factor Xa generation.

Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action.

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.

Pharmacokinetics of factor VIII and factor IX.

P2888

s12248-014-9627-2

P304

1038-1045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-014-9627-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Matthew P Kosloski

P577

2014-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263207516

http://www.w3.org/2001/XMLSchema#string

P6179

1001696594

http://www.w3.org/2001/XMLSchema#string

P698

24934295

http://www.w3.org/2001/XMLSchema#string

P932

4147049

http://www.w3.org/2001/XMLSchema#string